Redcare Pharmacy NV provided earnings guidance for the full year 2023. For the year, the company confirmed the guidance of net sales EUR 1.7 billion to EUR 1.8 billion.
Market Closed -
Other stock markets
|
After market 03:58:00 pm | |||
116.4 EUR | +1.84% | 116.6 | +0.17% |
08:28am | REDCARE PHARMACY : Jefferies gives a Buy rating | ZD |
May. 28 | REDCARE PHARMACY : Buy rating from Jefferies | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.55% | 2.53B | |
-38.95% | 13.9B | |
-32.35% | 10.68B | |
-16.27% | 7.12B | |
+10.79% | 6.24B | |
-11.61% | 5.96B | |
+73.30% | 4.72B | |
-3.50% | 4.56B | |
-6.67% | 3.87B | |
-19.80% | 3.17B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Redcare Pharmacy NV Provides Earnings Guidance for the Full Year 2023